Tuesday, January 20, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Asian Markets

India’s Investment Paradox: Domestic Boom Meets Foreign Exodus

Robert Sasse by Robert Sasse
September 5, 2025
in Asian Markets, Emerging Markets, ETF, Market Commentary
0
Franklin FTSE India ETF Stock
0
SHARES
187
VIEWS
Share on FacebookShare on Twitter

India’s economy is demonstrating remarkable strength, creating an intriguing contrast with the significant withdrawal of foreign capital. The Franklin FTSE India ETF (FLIN) captures this exact dichotomy, presenting investors with a complex performance picture shaped by opposing market forces.

Stellar Growth Amidst Capital Flight

The nation’s economic engine is firing impressively, with real GDP expanding by 7.8% during the first quarter of the 2025-26 fiscal year. This represents the most robust growth rate witnessed in five consecutive quarters. A supercharged manufacturing and services sector is primarily driving this exceptional performance.

Manufacturing activity reached a notable milestone in August, achieving a Purchasing Managers’ Index (PMI) reading of 59.8, its highest level in seventeen years. The services sector outperformed even this, posting a record-breaking PMI of 62.9. Surging domestic demand, partly accelerated by companies front-running anticipated new U.S. tariffs, is fueling this expansion.

This powerful economic backdrop makes the behavior of foreign institutional investors (FIIs) particularly striking. Contrary to what one might expect, they have been substantial net sellers. Hard data reveals a withdrawal of ₹46,902 crore in August alone. The cumulative outflow since the start of the year has now surpassed ₹1.16 lakh crore, equivalent to approximately $13.23 billion.

Sectoral Shifts and Domestic Counterweights

The retreat of foreign capital has not been uniform across the market. The financial and information technology sectors have borne the brunt of the selling pressure, experiencing outflows exceeding ₹60,000 crore over July and August. Analysts point to a stronger U.S. dollar, rising global interest rates, and significant trade policy disruptions as the key drivers behind this exodus.

However, a powerful countervailing force has emerged to provide market stability. Domestic institutional investors (DIIs) have been injecting capital at a formidable pace, deploying nearly ₹95,000 crore into Indian equities in August. This substantial domestic buying power has effectively cushioned the market from the full impact of foreign selling.

Trade Tensions and Policy Responses

International trade relations have introduced substantial headwinds. In a significant escalation, the U.S. administration doubled down on its trade policy in August, raising tariffs on certain Indian exports from 25% to 50%. This decision was directly linked to India’s continued import of Russian oil. Key export categories including textiles, gemstones, and solar products have been most affected by these measures.

Should investors sell immediately? Or is it worth buying Franklin FTSE India ETF?

In response, Indian policymakers are preparing a significant fiscal overhaul. Dubbed “GST 2.0,” a new two-tier tax structure with rates of 5% and 18% will replace the existing four-rate system effective September 22. The central objective of this reform is to bolster domestic consumption, creating an economic buffer against the impact of U.S. trade measures.

FLIN ETF: Composition and Vulnerabilities

The Franklin FTTE India ETF tracks the performance of the FTSE India Capped Index, which holds 267 constituent stocks. The fund maintains a moderately concentrated profile, with its top ten holdings accounting for 32.85% of the total portfolio weight.

The largest individual positions include:
* HDFC Bank: 6.85%
* Reliance Industries: 5.95%
* ICICI Bank: 4.70%
* Infosys: 3.38%
* Bharti Airtel: 3.31%

Recent performance among these major holdings highlights the market’s volatility. Reliance Industries declined by 4.56% over a three-month period, while Infosys dropped 6.97%. Tata Consultancy Services experienced a more significant correction of 9.55%. The fund’s substantial allocation to the financial sector—precisely the area experiencing the heaviest foreign outflows—represents a particular vulnerability in the current environment.

Performance Metrics and Market Realities

The ETF’s recent performance data presents a mixed picture that reflects these market tensions:
* Year-to-date return: +0.38%
* Three-month return: -0.78%
* One-year return: -6.42%
* July performance: -5.25%

Trading at a current price of $37.80, FLIN sits slightly above its last reported Net Asset Value (NAV) of $37.50. The fund maintains solid liquidity, with an average daily trading volume of 637,514 shares.

The critical question for investors is whether the ETF can ultimately outperform its benchmark index. Recent performance trends and the structural challenges posed by global trade conflicts introduce significant doubt. India’s economy continues its impressive expansion, yet its equity market must simultaneously navigate the complex realities of international political and trade disputes.

Ad

Franklin FTSE India ETF Stock: Buy or Sell?! New Franklin FTSE India ETF Analysis from January 20 delivers the answer:

The latest Franklin FTSE India ETF figures speak for themselves: Urgent action needed for Franklin FTSE India ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 20.

Franklin FTSE India ETF: Buy or sell? Read more here...

Tags: Franklin FTSE India ETF
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

XRP Stock
Analysis

XRP’s Diverging Path: Network Activity Soars as Price Struggles

January 20, 2026
MSCI World ETF Stock
AI & Quantum Computing

A Global ETF’s American Heartbeat: How Tech Titans Drive the iShares MSCI World Fund

January 20, 2026
Southern Copper Stock
Commodities

Southern Copper Shares Pause Ahead of Earnings Release

January 20, 2026
Next Post
Opendoor Stock

Leadership Shift and Profit Surge Fuel Opendoor's Meteoric Stock Ascent

Oxford Lane Capital Stock

Oxford Lane Capital Implements 1-for-5 Reverse Stock Split

Whirlpool Stock

Whirlpool Faces Mounting Pressure from Analysts and Legal Disputes

Recommended

Reliance Steel, Aluminum Stock

Reliance Inc.: The Unassuming Titan in Metals Distribution

5 months ago
CL stock news

Strs Ohio Demonstrates Confidence in Primerica’s Potential with Strategic Investment

2 years ago
Robinhood Stock

Robinhood Shares Plunge as Insider Selling Adds to Market Woes

2 months ago
Reynolds Consumer Products Stock

Institutional Investors Flock to Packaging Giant Amid Market Uncertainty

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Insmed Stock Analysis: Balancing Robust Revenue with Clinical Trial Volatility

A Global ETF’s American Heartbeat: How Tech Titans Drive the iShares MSCI World Fund

FutureFuel Shares Maintain Upward Momentum as Strategy Gains Traction

A Strategic Stake and a Historic Discovery: Max Power Mining Gains Momentum

Synopsys Stock Navigates Strategic Shift Amid Divergent Investor Views

Southern Copper Shares Pause Ahead of Earnings Release

Trending

Eos Energy Enterprises Stock
Analysis

Eos Energy Unveils Next-Generation Storage Platform Amid Leadership Transition

by Felix Baarz
January 20, 2026
0

Eos Energy Enterprises has captured market attention through a dual announcement: a shift in its board leadership...

XRP Stock

XRP’s Diverging Path: Network Activity Soars as Price Struggles

January 20, 2026
Sangamo Therapeutics Stock

Can Sangamo Therapeutics Reach Profitability by 2027?

January 20, 2026
Insmed Stock

Insmed Stock Analysis: Balancing Robust Revenue with Clinical Trial Volatility

January 20, 2026
MSCI World ETF Stock

A Global ETF’s American Heartbeat: How Tech Titans Drive the iShares MSCI World Fund

January 20, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eos Energy Unveils Next-Generation Storage Platform Amid Leadership Transition
  • XRP’s Diverging Path: Network Activity Soars as Price Struggles
  • Can Sangamo Therapeutics Reach Profitability by 2027?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com